When was CoreMap founded?

CoreMap was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is CoreMap located?

CoreMap is headquartered in Burlington, United States.

Who is the current CEO of CoreMap?

Sarah O'Connell Kalil of CoreMap.

How many employees does CoreMap have?

As of Aug 31, 2026, the latest employee count at CoreMap is 48.

Is CoreMap a funded company?

CoreMap is a funded company, having raised a total of $68.3M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 25, 2017.

When was the latest funding round of CoreMap?

CoreMap's latest funding was a $***** Series C round on Jun 18, 2026, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.33B in funding in 2026 to date.

Where does CoreMap rank among its competitors?

CoreMap ranks 1st amongst 12 active competitors, of which 4 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was CoreMap, which secured $37M in Jun, 2026.

Who are the top competitors of CoreMap?

CoreMap's top competitors include Wearlinq, Topera and Cardinor. Among them, CoreMap secured the most recent funding round in June, 2026.

CoreMap - 2026 Company Profile, Team, Funding & Competitors

CoreMap is a series C company based in Burlington (United States), founded in 2017. It operates as a Provider of platform to detect atrial fibrillation to manage heart disorders. CoreMap has raised $68.3M in funding from Qure Ventures and Medtronic. The company has 12 active competitors, including 4 funded and 1 that has exited. Its top competitors include companies like Wearlinq, Topera and Cardinor.

Company Details

Provider of platform to detect atrial fibrillation to manage heart disorders. The company develops a cardiac electrophysiology mapping software that integrates with a diagnostic catheter to detect the patient's atrial fibrillation. The AF vitals help in better clinical decisions and health outcomes for the patients.

Key Metrics

Founded Year

2017

Location

Burlington, United States

Stage

Series C

Total Funding

$68.3M in 7 rounds

Latest Funding Round

Series C, Jun 18, 2026, $*****

Investors

Qure Ventures & 8 more

Ranked

1^st among 12 active competitors

Employee Count

48 as on Aug 31, 2026

Similar Companies

Wearlinq & 18 more

View CoreMap's full profile

CoreMap has raised a total funding of $68.3M over 7 rounds. Its first funding round was on Sep 25, 2017. Its latest funding round was a Series C round on Jun 18, 2026 for $*****. 1 investor participated in its latest round. CoreMap has 7 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of CoreMap:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 18, 2026	9060365	Series C	3383957	5408223	3453223	5503511
Feb 10, 2022	9193760	Series B	7003125	5670107	9384954	Russ Scully
Sep 17, 2020	5857279	Series A	7524422	4012673	Qure Ventures	Ronny Ginor

Access funding benchmarks and valuations. Sign up today!

View details of CoreMap's funding rounds and investors

CoreMap's employee count trend

CoreMap has 48 employees as of Aug 26. Here is CoreMap's employee count trend over the years:

Uncover CoreMap's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CoreMap include Wearlinq, Topera and Cardinor. Here is the list of Top 10 competitors of CoreMap, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CoreMap 2017, Burlington (United States), Series C	Provider of platform to detect atrial fibrillation to manage heart disorders	$68.3M	Medtronic, Qure Ventures & 7 others	57/100
2nd	Wearlinq 2019, Stanford (United States), Series A	Provider of wearable ECG monitoring device to detect heart disorders	$26.3M	Smartlink Partners, Maliam & 14 others	46/100
3rd	Topera 2010, Menlo Park (United States), Acquired	Catheter-based electrophysiology for treatment of atrial fibrillation	$31.5M	Vensana Capital, Questa Capital & 3 others	43/100
4th	Cardinor 2015, Oslo (Norway), Seed	Provider of biomarker-based assays for cardiovascular diseases	$922K	IIG, EIC Fund & 2 others	34/100
5th	Bionet 1999, Seoul (South Korea), Unfunded	Suite of monitoring medical device	-	-	30/100
6th	Cardio-Phoenix 2006, Markham (Canada), Seed	Provider of AI- based diagnostic for cardiac diseases	-	-	25/100
7th	eWaveMD 1999, Ra'anana (Israel), Unfunded	eWaveMD offers eHealth solutions which allow to providing health services in rural areas.	-	-	25/100
8th	American Medical Technologies 2012, Wauwatosa (United States), Unfunded	Innovative medical device company focused on cardiac electrophysiology solutions	-	-	24/100
9th	Trismed 2000, Daejeon (South Korea), Unfunded	Diagnostic tools for heart diseases	-	-	24/100
10th	MediLynx 2000, Plano (United States), Deadpooled	Provider of cardiac monitoring system	-	-	24/100